Über diesen Podcast
Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Oncology & Hematology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives. Inspiring and engaging programs designed for oncologists and hematologists to cover the diagnosis, staging, treatment, follow-up, and clinical management of tumors and hematological malignancies. Earning your CME/CE credits has never been faster…
159 Folgen · science
CME in Minutes: Education in Oncology & Hematology
Über diesen Podcast
Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Oncology & Hematology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives. Inspiring and engaging programs designed for oncologists and hematologists to cover the diagnosis, staging, treatment, follow-up, and clinical management of tumors and hematological malignancies. Earning your CME/CE credits has never been faster…
Neue Folgen
- Going Beyond the Guidelines: Incorporating Patient and Disease Factors to Optimize First-Line Treatment Strategies in LA/mUC1. Sept. · 25 Min.
- Evolving Insights Into EZH 1/2 Inhibition in B- and T-Cell Lymphoma: Expert Perspectives on Latest Advancements28. Aug. · 21 Min.
- Answering Clinician Questions About Anemia in Lower-Risk Myelodysplastic Syndromes: Community-Based Strategies to Enhance Long-Term Efficacy27. Aug. · 20 Min.
- Redefining What’s Possible in mTNBC: The Expanding Frontier of TROP2-Directed ADCs17. Aug. · 15 Min.
- Conversations in Gene Expression–Based Testing: A Clinician’s Roadmap to Multidisciplinary Melanoma Care13. Aug. · 22 Min.
- From Biology to Best Practice: Sequencing Current and Emerging Therapies in EGFR-Mutated NSCLC Beyond Progression12. Aug. · 36 Min.
- Optimizing Frontline Care in NDMM: Translating Recent Advances Into Practice7. Aug. · 1 Std. 07 Min.
- Adapting to Evolution for Second-Line Treatment in EGFR-Mutated Advanced NSCLC: Understanding Tumor Biology to Elevate the Therapeutic Strategy5. Aug. · 32 Min.
- Integrating ESR1m Testing and Novel Oral SERDS Into Multidisciplinary Workflows: Regional Guidance for HR+, HER2- Advanced Breast Cancer4. Aug. · 1 Std. 03 Min.
- Integrating ESR1m Testing and Novel Oral SERDS Into Multidisciplinary Workflows: Regional Guidance for HR+, HER2- Advanced Breast Cancer3. Aug. · 1 Std. 06 Min.
podlinkr.com/de/cme-in-minutes-education-in-oncology-and-hematol
Für ein Plakat oder eine Folie.